micro dosing glp-1 What should you know before starting a GLP-1? GLP-1 microdosing is popular, but

In 2024, Australia and New Zealand approved allulose as a novel food and safe ingredient

UCLA physicians have pointed out that the common risk of significant weight loss on GLP-1 drugs is being accompanied by sarcopenia, which can cause long-term negative health implications, such as increased fracture risk, decreased mobility, lowered metabolism, and reduced quality of life

DSIP Research# DSIP has a larger but lower-quality evidence base that includes human data: Schneider-Helmert (1987) -- reported acute sleep-inducing effects of IV DSIP in normal subjects, with sleep increased 59% within a 130-minute observation window Schneider-Helmert & Schoenenberger (1992) -- double-blind study in chronic insomniacs showing improved sleep efficiency

M.et al (2025)